Search company, investor...
Search

Predict your next investment

RapidAI company logo
Corporation
SOFTWARE (NON-INTERNET/MOBILE) | Healthcare Software
rapidai.com

See what CB Insights has to offer

Partners & Customers

10

About RapidAI

RapidAI is using AI to combat life-threatening vascular and neurovascular conditions. From home to hospital and ER to OR, RapidAI is leading the next evolution of clinical decision-making and patient workflow, bringing the end-to-end patient journey into focus.

RapidAI Headquarters Location

San Mateo, California,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing RapidAI

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find RapidAI in 1 Expert Collection, including Cancer.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

RapidAI Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

RapidAI Rank

Research containing RapidAI

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned RapidAI in 1 CB Insights research brief, most recently on Apr 12, 2022.

Latest RapidAI News

10:54 EDT RapidAI Applauded by Frost & Sullivan for Delivering Quality Care Quickly and Securely With Its RapidAI Platform

Sep 12, 2022

News provided by Share this article Share this article The fast, accurate, and proven RapidAI platform improves patient and staff experience and diagnostic accuracy, ensures high care team coordination, better health outcomes, and reduces costs. SAN ANTONIO, Sept. 12, 2022 /PRNewswire/ -- Frost & Sullivan recently analyzed the artificial intelligence (AI) algorithms for the stroke market, and, based on its assessment results, recognizes RapidAI with the 2022 Global Technology Innovation Leadership Award. The company is a leading provider of advanced imaging for stroke. It is a pioneer in AI-based treatment for vascular and neurovascular conditions and offers innovative solutions for more stroke diagnosis modalities than any other company in the space. RapidAI's world-class subject matter experts developed advanced cerebrovascular imaging and workflow solutions over the last decade. The company refined its holistic approach to care for life-threatening neurovascular and vascular conditions, continuously building its comprehensive software platform to bridge the care gaps. The RapidAI solution is clinically validated and uses AI to create high-quality, advanced brain images from non-contrast computed tomography (CT), CT angiography, CT perfusion, and magnetic resonance imaging (MRI) diffusion and perfusion studies. With the largest number of modules in the stroke space having top sensitivity and specificity levels, the RapidAI platform: Delivers value for various hospital environments and applications, ranging from emergency departments and trauma centers to acute stroke-ready hospitals, primary stroke centers, and comprehensive stroke centers. Improves diagnostic accuracy, ensures high care team coordination, and brings unparalleled value to customers. Allows for early identification of suspected stroke patients using AI-based software solutions to expedite triage and transfer decisions. Gives valuable insights to increase efficiency and standardize processes. According to Pavel Zhebrouski, a Frost & Sullivan Best Practices Research Analyst, "By automating and optimizing the entire workflow, from pre-hospital to the patient care pathway, RapidAI can save hospitals time and money, improve outcomes, and enable faster intervention. The AI-based solution allows comprehensive stroke center care teams to connect quickly with the primary stroke centers before patient transfer and prepare for the proper intervention." The RapidAI platform revolutionizes clinical decision-making and patient workflow, focusing on the end-to-end patient journey. It empowers clinicians to provide time-sensitive treatment and faster diagnosis. The platform helps vascular or neurovascular clinical care teams to save time while communicating and updating patient status through messaging, new case notifications, and rapid results delivery. The powerful AI-based clinical platform streamlines the triage, transfer, and treatment workflow, modernizing healthcare standards at scale and offering quality care to patients. "The RapidAI platform has clinical decision support modules, patient care workflow solutions, and analytic insights for various diseases. It changes the paradigm of stroke care and supports other disease areas for better patient outcomes," said Dr. Eishita Pal, a Frost & Sullivan Industry Analyst. For its strong overall performance, RapidAI earns Frost & Sullivan's 2022 Global Technology Innovation Leadership Award in the artificial intelligence algorithms for the stroke market. Each year, Frost & Sullivan presents this award to the company that develops a product with innovative features and functionality that is gaining rapid acceptance in the market. The award recognizes the quality of the solution and the customer value enhancements it enables. Frost & Sullivan Best Practices awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry. About Frost & Sullivan For six decades, Frost & Sullivan has been world-renowned for helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion . Contact:

RapidAI Acquisitions

1 Acquisition

RapidAI acquired 1 company. Their latest acquisition was EndoVantage on June 09, 2020.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

6/9/2020

Other

$99M

$0.01M

Acquired

6

Date

6/9/2020

Investment Stage

Other

Companies

Valuation

$99M

Total Funding

$0.01M

Note

Acquired

Sources

6

RapidAI Partners & Customers

10 Partners and customers

RapidAI has 10 strategic partners and customers. RapidAI recently partnered with Life Image on June 6, 2020.

Date

Type

Business Partner

Country

News Snippet

Sources

6/24/2020

Partner

United States

Life Image Announces a Partnership with RapidAI to Accelerate the Adoption of Life-Saving Stroke Technology to Hospitals

The partnership extends the availability of Rapid ® 's life-saving neuroimaging platform through Life Image 's cloud network -- facilitating direct connections between organizations that benefit from stroke imaging collaboration .

6

7/23/2015

Partner

United States

InTouch Health and iSchemaView Partner to Improve Care for Stroke Victims

At the 9th Telehealth Innovation Forum , InTouch Health today announced an exclusive global telehealth partnership with iSchemaView to integrate iSchemaView 's RAPID diagnostic tool into InTouch Health 's industry-leading telestroke solution .

3

7/23/2015

Partner

United States

Press Releases - InTouch Health InTouch Health and iSchemaView Partner to Improve Care for Stroke Victims. Envision Healthcare and InTouch Health Partner to Provide Comprehensive Telemedicine Clinical Services.

http://34.192.167.134/wp-content/uploads/2015/06/header-logo-88h.png00InTouch Health Administratorhttp : / / 34.192.167.134 / wp-content/uploads/2015 / 06/header-logo -88 h.pngInTouch Health Administrator2015-07-23 09:55:222016 -09 -28 10:16:37 InTouch Health and iSchemaView Partner to Improve Care for Stroke Victims .

1

1/1/2000

Partner

United States

Subscribe to see more

Subscribe to see more

0

1/1/2000

Partner

United States

Subscribe to see more

Subscribe to see more

0

Date

6/24/2020

7/23/2015

7/23/2015

1/1/2000

1/1/2000

Type

Partner

Partner

Partner

Partner

Partner

Business Partner

Country

United States

United States

United States

United States

United States

News Snippet

Life Image Announces a Partnership with RapidAI to Accelerate the Adoption of Life-Saving Stroke Technology to Hospitals

The partnership extends the availability of Rapid ® 's life-saving neuroimaging platform through Life Image 's cloud network -- facilitating direct connections between organizations that benefit from stroke imaging collaboration .

InTouch Health and iSchemaView Partner to Improve Care for Stroke Victims

At the 9th Telehealth Innovation Forum , InTouch Health today announced an exclusive global telehealth partnership with iSchemaView to integrate iSchemaView 's RAPID diagnostic tool into InTouch Health 's industry-leading telestroke solution .

Press Releases - InTouch Health InTouch Health and iSchemaView Partner to Improve Care for Stroke Victims. Envision Healthcare and InTouch Health Partner to Provide Comprehensive Telemedicine Clinical Services.

http://34.192.167.134/wp-content/uploads/2015/06/header-logo-88h.png00InTouch Health Administratorhttp : / / 34.192.167.134 / wp-content/uploads/2015 / 06/header-logo -88 h.pngInTouch Health Administrator2015-07-23 09:55:222016 -09 -28 10:16:37 InTouch Health and iSchemaView Partner to Improve Care for Stroke Victims .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

6

3

1

0

0

RapidAI Team

9 Team Members

RapidAI has 9 team members, including , .

Name

Work History

Title

Status

Greg Albers

Founder

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Greg Albers

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Founder

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

You May Also Like

Viz.ai Logo
Viz.ai

Viz.ai aims to use artificial intelligence and deep learning to automatically identify suspected LVOs (large vessel occlusion) on CTA imaging with the aim of alerting a patient's physician within minutes. The company was founded in 2016 and is based in San Francisco, California.

A
Aidoc Medical

Aidoc finds and flags critical findings in medical images. By automatically prioritizing urgent, life-threatening conditions like intracranial hemorrhage and pulmonary embolism, Aidoc saves lives, improves patient care and cuts waiting time for the must urgent patients down to only a few minutes. The always-on AI integrates into a radiologist's workflow, reprioritizing cases without forcing radiologists to change the way they work. Aidoc was founded in 2016 and is based in Tel Aviv, Israel.

R
RadNet

RadNet is a national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. The company has a network of 293 owned and/or operated outpatient imaging centers.

ScreenPoint Medical Logo
ScreenPoint Medical

ScreenPoint Medical, based in Nijmegen, has developed smart software for improving results of breast cancer screening. This software reads mammograms like a human reader and supports radiologists by identifying and interpreting potential problem areas on x-ray images. This reduces the chance of missing tumors and may be used to organize screening more efficiently.

Perspectum Logo
Perspectum

Perspectum is a provider of digital technologies that help clinicians provide better care for patients with liver disease. The company's work focuses on the detection and accurate, quantitative measurement of liver, gall bladder, and pacreatic disease.

Koios Medical Logo
Koios Medical

Koios Medical is a provider of software solutions for radiologists diagnosing cancer. Using AI algorithms trained on thousands of images combined with data from pathology results, Koios DS™ is decision support for healthcare diagnostics. Koios Medical was formerly known as Clearview Diagnostics. The company was founded in 2012 and is based in Chicago, Illinois.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.